VDF FutureCeuticals – Trademark Portfolio

Entity Type: 03

VDF FutureCeuticals holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include VITABLUE, VITACRAN, VITABERRY, and VITACHERRY. The owner is based in Momence, IL.

300 W. Sixth Street

Momence, IL 60954

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

VDF FutureCeuticals's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (10 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does VDF FutureCeuticals have?

VDF FutureCeuticals has 11 U.S. trademarks filed with the USPTO. Of these, 5 registered, 3 abandoned, 3 cancelled.

What trademark classes does VDF FutureCeuticals file in?

VDF FutureCeuticals files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are VDF FutureCeuticals's most well-known trademarks?

VDF FutureCeuticals's registered trademark portfolio includes well-known marks such as VITABLUE, VITACRAN, VITABERRY, and VITACHERRY. These are among 5 currently registered trademarks in the portfolio.

What is VDF FutureCeuticals's trademark registration success rate?

VDF FutureCeuticals has a 45% trademark registration rate, with 5 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.